GENE ONLINE|News &
Opinion
Blog

2021-09-07| In-DepthSpecial

Researchers Engineer “Mini” CRISPR-Cas System That Could Act as ‘Swiss Army Knife’ for Mammalian Genome Editing

by Isha Kapoor
Share To
A team of researchers at Stanford University have engineered a highly compact and versatile CRISPR-Cas system for mammalian genome editing and regulation, which is less than half the size of currently used CRISPR Cas9 or Cas12a systems. Strikingly though, they have levels of gene activation comparable to that of Cas12a.

The scientists believe that its diminutive size would facilitate high-efficiency transport for a wide range of genome engineering applications that require the delivery of compact Cas-fusion proteins for varied cellular functions.

In a recent report published in Molecular Cell, the researchers state that this engineered, efficient, specific, compact, versatile, and multi-purpose “mini” CRISPR-Cas system could serve as a “Swiss Army knife” in mammalian genome editing.

GO Prime with only $1.49 now

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top